Cartalax Peptide Overview
Generic and Brand Names: Cartalax. It is also referred to as AED tripeptide or the peptide of Khavinson’s family. There are no brand names for Cartalax approved by the FDA or specific treatments involving the drug. Although the drug is sold as a bioregulator in Russia, it is classified as an investigational research peptide everywhere outside the country, with no marketing rights to any medications.
Drug Classification: The drug is a synthetic bioregulatory peptide, a chondroprotective agent that works at the molecular level without other classes of medications.
Chemical Properties: The chemical compound and structure of Cartalax are that of a low-molecular-weight peptide. The drug is made of three amino acids: Alanine, Glutamic acid, and Aspartic acid. Cartalax peptide is similar to the sequence in type XI collagen, which is a vital part of human cartilage. The chemical compound is stable and not destroyed when in the body.
Compliance & Research Disclaimer
Cartalax Peptide is for research use only and academic experimental purposes. It is not registered as a pharmaceutical drug, dietary supplement or an over-the-counter medicine and has no clinical use approval from the FDA, EMA or other regional medical regulatory body. The product cannot be used for human clinical diagnosis, treatment of disease, oral or intravenous administration as well as commercial off-label usage. All of the product details and research data is academic in nature and not intended as medical advice or to be construed as therapeutic claims. Local laws, institutional laboratory-management requirements, and ethical-research standards must be followed by all purchasers and researchers. We shall not be liable for any unauthorized illegal use, improper operation or non-research application of the product.
- Mechanism of Cartalax Work
1.1 Receptor Activation. Activation of Cartalax happens through a special mechanism that doesn’t involve traditional receptors like GPCRs. The drug enters the cell and interacts directly with the gene promoter in the cell nucleus. Thus, the drug works on specific genes responsible for the formation of cartilage, but this does not involve unwanted activation of other receptors, which is an advantage while using the compound.
1.2 Metabolic and physiological impact
In addition to its main chondroprotective effect, Cartalax has other metabolic and physiological effects that are extensively researched in preclinical studies. It increases the production of type II collagen and proteoglycans in order to protect cartilage from destruction, while inhibiting production of local pro-inflammatory cytokines, and thereby reducing the level of low-grade chronic inflammation which causes metabolic diseases. By providing the body with an optimal inflammatory status, it improves peripheral insulin sensitivity and ensures the stability of glucose metabolism in type 2 diabetes patients. It also regulates inflammatory reactions in adipose tissues for prevention of obesity-related metabolic disorders and assists in the measurement of fat mass. In addition to anti-inflammatory and tissue protective effects, it minimizes inflammation and metabolic disorder caused by intermittent hypoxia.
- Applications
All laboratory studies with Cartalax are limited to preclinical research as there are no clinical indications for its usage in humans approved by the FDA.
Research in type 2 diabetes mellitus: It has been investigated in preclinical studies aimed at the diagnosis of insulin resistance and its treatment through the reduction of inflammation in the body in order to make the body react to glucose properly.
Chronic weight management: It has been used in obesity studies to determine the effects of inflammation on metabolism and find ways to improve the organisms' metabolic environment in order to properly treat obesity.
Obstructive sleep apnea: It has been used in studies that focused on the inflammation caused by intermittent hypoxia and its effects on the glucose and lipid metabolism. The results of this research canCore Research in Chondroprotection: A significant element of experimental methodology applied at the development of degenerative processes in cartilage, treatment of intervertebral disk pathologies, and epigenetic regulation of connective tissue.
Dosage and Administration (Laboratory Protocol)
3.1 Route and Frequency
For the administration of Cartalax in everyday laboratory research, subcutaneous injection is the common route chosen since it enables the proper absorption and distribution throughout the body, accordingly giving reliable results in epigenetic and metabolic intervention. It is customary in research to perform administration with the help of the procedure of pulsed cyclical administration with one injection a day for 10-20 days, meaning that 2-3 prescriptions of Cartalax are usually performed per year during chronic experiments.
3.2 Titration
The baseline dose for preclinical animal tests is from 100-150 mcg per day for low levels of gene regulation and inflammation. The medium needed dose for research work is 200-400 mcg per day, reaching the necessary results. The highest available dose is from 500 mcg per day to avoid the alteration in gene expression. There are no established protocols for the usage of Cartalax in humans.
3.3 Missed Dose Management
The missed doses of Cartalax do not need to be addressed in standardized protocols. The missed dose is noted in the dose log where the timings of missing doses have to be kept, cycles being maintained. The results will be achieved without compensating for the dose because such procedures lead to false modifications of results in gene regulation and intervention processes.
- Dosage Forms
The only available form of research-grade Cartalax is the lyophilized powder that must be done correctly. The reconstitution procedure with sterile water is carried out before the injection. There are no available oral forms or injections.
- FDA Regulatory Status
The Food and Drug Administration has not approved Cartalax peptide for any purposes and considers it only an experimental research peptide without the possibility of commercial sales. The Food and Drug Administration does not allow the use of Cartalax in humans.
10 Common FAQs About Peptides
- What is a peptide?
Answer: A peptide is a short chain of amino acids linked together by peptide bonds. It is smaller and more easily absorbed by the human body than proteins, serving as a fundamental functional substance in biological organisms.
- What is the difference between peptides and proteins?
Answer: The core difference lies in molecular length and structure. Peptides are short amino acid chains (usually consisting of 2–50 amino acids), while proteins are long, complex amino acid chains with stable three-dimensional structures. Peptides have stronger permeability and faster absorption efficiency than proteins.
- What are the main types of peptides?
Answer: Peptides are mainly classified by the number of amino acids: dipeptides, tripeptides, oligopeptides (2–10 amino acids) and polypeptides (10–50 amino acids). They can also be divided into natural peptides and synthetic peptides according to their sources.
- What are the biological functions of peptides?
Answer: Peptides have diverse biological activities, including regulating human metabolism, improving immune function, promoting cell repair, anti-oxidation, anti-aging, and adjusting hormone levels. They act as key signaling molecules and regulatory factors in the body.
- Are peptides safe for human use?
Answer: Most natural and medically approved synthetic peptides are highly safe. They have small molecular weight, low toxicity, and will not accumulate in the body. However, unstandardized high-dose peptide products or impure synthetic peptides may cause mild discomfort.
- What are the common applications of peptides?
Answer: Peptides are widely used in multiple fields. In biomedicine, they are made into therapeutic drugs for endocrine and immune diseases; in cosmetics, they are used for anti-aging and skin repair; in health products, they serve as nutritional supplements to improve physical fitness.
- Can the human body absorb exogenous peptides directly?
Answer: Yes. Unlike proteins that need to be decomposed before absorption, small-molecule peptides can be directly absorbed by the intestinal tract and skin with high absorption rate and utilization efficiency, and can quickly exert biological effects in the body.
- What are synthetic peptides used for?
Answer: Synthetic peptides are artificially customized amino acid chains. They are mainly used for scientific research, clinical drug development, targeted skin care ingredient production, and precise nutritional supplementation, with higher purity and targeted activity than some natural peptides.
- Do peptide products have side effects?
Answer: Standard peptide products have almost no obvious side effects for most people. Individual groups may experience mild gastrointestinal discomfort or skin sensitivity due to physical differences or excessive intake. Long-term excessive use may disrupt the body’s metabolic balance.
- What is the difference between collagen peptides and ordinary peptides?
Answer: Collagen peptides are a specific type of functional peptide extracted and decomposed from collagen, mainly targeting skin moisturizing, anti-wrinkle and joint care. Ordinary peptides cover a broader range with more diverse regulatory functions including immunity and metabolism, while collagen peptides have more focused skincare and anti-aging effects.
All of our fiber optic cable package are with export wooden drum. Indoor FTTH cable’s wooden dimension is 50x50x32cm, delivery length 3km/drum, Outdoor fiber optic cable’s wooden dimension is 110cm*110cm*70cm, 0.85CBM, can be load about 33 drums for a 20GP.Also accept custom cable drum from customers. welcome to contact us!
GYTS Direct Burial Single Armored Double Sheath Fiber Optic Cable
GYTS Fiber Optic Cable Picture
Shipping Choice |
| Shipping method | Courier | Shipping Time |
| Express Shipping | UPS | 5-15 DAY |
| Fedex | 5-15 DAY |
| Dedicated line | USPS | 7-15 DAY |
| Fedex | 7-15 DAY |
| DDP | | 10-20 DAY |
